Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
![]() |
![]() ![]() |
Ultima descărcare din IBN: 2024-05-30 19:14 |
![]() ARUTYUNOV, G., TARLOVSKAYA, E., ARUTYUNOV, A., BELENKOV, Yu., KONRADI, Aleksandra, LOPATIN, Yu., REBROV, Andrey, TERESHCHENKO, Sergey, CHESNIKOVA, Anna, AIRAPETYAN, G., BABIN, Aleksandr, BAKULIN, I., NOI, Autori, BUDU, Angela, PETROV, Liviu. Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry "dynamics analysis of comorbidities in SARS-CoV-2 infection survivors". In: Russian Journal of Cardiology, 2022, vol. 27, pp. 16-30. ISSN 1560-4071. DOI: https://doi.org/10.15829/1560-4071-2022-5042 |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Russian Journal of Cardiology | |
Volumul 27 / 2022 / ISSN 1560-4071 | |
|
|
DOI:https://doi.org/10.15829/1560-4071-2022-5042 | |
Pag. 16-30 | |
![]() |
|
Rezumat | |
Aim. To study the lipid profile in hospitalized patients with coronavirus disease 2019 (COVID-19) depending on the outcome of its acute phase according to the AKTIV international registry. Material and methods. The AKTIV registry included men and women over 18 years of age with a diagnosis of COVID-19, who were treated in a hospital. A total of 9364 patients were included in the registry, of which 623 patients were analyzed for levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglycerides on days 1-2 of hospitalization. The level of high-density lipoprotein cholesterol (HDL-C) was calculated using the Friedewald equation. Results. We found that a decrease in LDL-C level was significantly associated with an unfavorable prognosis for hospitalized patients with COVID-19. This pattern persisted in both univariate and multivariate analyses. LDL-C levels in the final multivariate model had a significant relationship with the prognosis (an increase in the death risk by 1,7 times with a decrease per 1 mmol/l). In addition, we found that the survival of patients with an indicator level of <2,45 mmol/l is significantly worse than in patients with an LDL-C level ≥2,45 mmol/l. All patients with high LDL-C ((≥4,9 mmol/l) survived, while among patients with low LDL-C ([removed]. |
|
Cuvinte-cheie cholesterol, high density lipoprotein cholesterol, low density lipoprotein cholesterol, triacylglycerol |
|
|
DataCite XML Export
<?xml version='1.0' encoding='utf-8'?> <resource xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xmlns='http://datacite.org/schema/kernel-3' xsi:schemaLocation='http://datacite.org/schema/kernel-3 http://schema.datacite.org/meta/kernel-3/metadata.xsd'> <identifier identifierType='DOI'>10.15829/1560-4071-2022-5042</identifier> <creators> <creator> <creatorName>Arutyunov, G.P.</creatorName> <affiliation>Asociația Eurasiatică a Terapeuților, Moscova, Rusia</affiliation> </creator> <creator> <creatorName>Tarlovskaya, E.I.</creatorName> <affiliation>Asociația Eurasiatică a Terapeuților, Moscova, Rusia</affiliation> </creator> <creator> <creatorName>Arutyunov, A.G.</creatorName> <affiliation>Asociația Eurasiatică a Terapeuților, Moscova, Rusia</affiliation> </creator> <creator> <creatorName>Belenkov, Y.N.</creatorName> <affiliation>Первый Московский государственный медицинский университет им. И.М. Сеченова, РАМН, Rusia</affiliation> </creator> <creator> <creatorName>Konradi, A.O.</creatorName> <affiliation>Almazov National Medical Research Centre, Rusia</affiliation> </creator> <creator> <creatorName>Lopatin, Y.M.</creatorName> <affiliation>Universitatea de medicină din Volgograd, Rusia</affiliation> </creator> <creator> <creatorName>Rebrov, A.P.</creatorName> <affiliation>Саратовский государственный медицинский университет им. В. И. Разумовского, Rusia</affiliation> </creator> <creator> <creatorName>Tereshchenko, S.N.</creatorName> <affiliation>Centrul național de cercetări medicale în Cardiologie E. I. Chazov, Rusia</affiliation> </creator> <creator> <creatorName>Chesnikova, A.I.</creatorName> <affiliation>ГОУ ВПО Ростовский государственный медицинский университет, Rusia</affiliation> </creator> <creator> <creatorName>Airapetyan, G.G.</creatorName> <affiliation>Centrul Medical Erebuni, Erevan, Armenia</affiliation> </creator> <creator> <creatorName>Babin, A.P.</creatorName> <affiliation>Universitatea de Stat de Medicină şi Farmacie „Nicolae Testemiţanu“, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Bakulin, I.G.</creatorName> <affiliation>Северо-Западный Государственный Медицинский Университет им. И.И.Мечникова, Rusia</affiliation> </creator> <creator> <creatorName>Noi, A.</creatorName> </creator> <creator> <creatorName>Budu, A.M.</creatorName> <affiliation>Spitalul Clinic Orăşenesc nr.1, Moldova, Republica</affiliation> </creator> <creator> <creatorName>Petrov, L.D.</creatorName> <affiliation>Centrul de Sănătate Publică Briceni, Moldova, Republica</affiliation> </creator> </creators> <titles> <title xml:lang='en,ru'>Lipid profile in hospitalized patients with covid-19 depending on the outcome of its acute phase: Data from the international registry "dynamics analysis of comorbidities in SARS-CoV-2 infection survivors"</title> </titles> <publisher>Instrumentul Bibliometric National</publisher> <publicationYear>2022</publicationYear> <relatedIdentifier relatedIdentifierType='ISSN' relationType='IsPartOf'>1560-4071</relatedIdentifier> <subjects> <subject>cholesterol</subject> <subject>high density lipoprotein cholesterol</subject> <subject>low density lipoprotein cholesterol</subject> <subject>triacylglycerol</subject> </subjects> <dates> <date dateType='Issued'>2022-09-14</date> </dates> <resourceType resourceTypeGeneral='Text'>Journal article</resourceType> <descriptions> <description xml:lang='en' descriptionType='Abstract'><p> </p><p>Aim. To study the lipid profile in hospitalized patients with coronavirus disease 2019 (COVID-19) depending on the outcome of its acute phase according to the AKTIV international registry. Material and methods. The AKTIV registry included men and women over 18 years of age with a diagnosis of COVID-19, who were treated in a hospital. A total of 9364 patients were included in the registry, of which 623 patients were analyzed for levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C) and triglycerides on days 1-2 of hospitalization. The level of high-density lipoprotein cholesterol (HDL-C) was calculated using the Friedewald equation. Results. We found that a decrease in LDL-C level was significantly associated with an unfavorable prognosis for hospitalized patients with COVID-19. This pattern persisted in both univariate and multivariate analyses. LDL-C levels in the final multivariate model had a significant relationship with the prognosis (an increase in the death risk by 1,7 times with a decrease per 1 mmol/l). In addition, we found that the survival of patients with an indicator level of <2,45 mmol/l is significantly worse than in patients with an LDL-C level ≥2,45 mmol/l. All patients with high LDL-C ((≥4,9 mmol/l) survived, while among patients with low LDL-C ([removed].</p></description> </descriptions> <formats> <format>application/pdf</format> </formats> </resource>